Making headway — a role for CGRP in post-traumatic headache

被引：0
作者：
Dimos D. Mitsikostas
Michael A. Moskowitz
机构：
[1] National and Kapodistrian University of Athens,1st Neurology Department, Aeginition Hospital, Medical School
[2] Massachusetts General Hospital,Departments of Radiology and Neurology
[3] Harvard Medical School,undefined
来源：
Nature Reviews Neurology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although common, post-traumatic headache remains poorly understood and poorly treated. New data have implicated calcitonin gene-related peptide and the trigeminovascular system in this disorder, opening up new avenues for research into its pathophysiology and treatment.
引用
收藏
页码：133 / 134
页数：1
相关论文
共 16 条
  • [1] Ashina H(2019)Post-traumatic headache: epidemiology and pathophysiological insights Nat. Rev. Neurol. 15 607-617
  • [2] Bree D(2020)Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model Cephalalgia 20 1224-1239
  • [3] Stratton J(2019)CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice Cephalalgia 39 1762-1775
  • [4] Levy D(2019)Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review J. Headache Pain 20 98-106
  • [5] Navratilova E(2020)Hypersensitivity to calcitonin gene-related peptide in post-traumatic headache Ann. Neurol. 87 939-949
  • [6] Larsen EL(2020)Extra-axial inflammatory signal in parameninges in migraine with visual aura Ann Neurol. 18 1864-1877
  • [7] Ashina H(2020)Migraine and the trigeminovascular system- 40 years and counting Lancet Neurol. 394 1765-1774
  • [8] Hadjikhani N(2019)Targeting calcitonin gene-related peptide: a new era in migraine therapy Lancet 30 1179-1186
  • [9] Ashina M(2010)Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura Cephalalgia 21 62-70
  • [10] Charles A(2020)Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study J. Headache Pain undefined undefined-undefined
12